Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THRIVE: FMT for Malnutrition
NCT03087097Phase 1Terminated
- Sponsor
- OpenBiome
- Start
- Apr 2019
- Primary completion
- Jul 2020
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in Malnutrition comparing Fecal Microbiota Transplant with Standard of Care (2 arms). Primary endpoint: Serious Adverse Events at 56 days. Started Apr 2019; status: terminated.
02
Drugs
fecal microbiome transplant
03
Conditions
Malnutrition
Beyond the preview
Go deeper on NCT03087097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03087097.